Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sectoral Funds – Weekly roundup - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Jul 8, 2000

    Sectoral Funds – Weekly roundup

    This week witnessed the BSE Sensex posting 3.3% appreciation. The last few weeks have seen a revival in old economy stocks with the new economy taking a backseat for a change. However, this does not prevent IT funds from outperforming the others.

    Open-ended, IT Funds NAV
    UTI Sector- Software 25.60 4.30% 12.30% 0.00% 96.20%
    DSP ML Tech.com (Gr) 10.09 4.20% 7.20% 0.00% 18.10%
    K P Internet Opport.(Gr) 9.01 4.00% 5.30% 0.00% -5.90%
    K P Infotech (Gr) 32.33 3.60% 9.10% 218.20% 180.30%
    Magnum Sector Funds-IT 17.71 3.00% 9.20% 0.00% 148.20%
    K Tech 8.56 2.60% 6.20% 0.00% 9.20%
    IL&FS eCOM Fund (Gr) 7.78 2.20% 11.60% 0.00% -42.90%
    Birla IT Fund (Gr) 22.85 2.20% 4.80% 102.00% 18.20%
    Chola Freedom Tech (Cum) 17.75 1.40% 9.40% 28.30% 25.40%
    Pru ICICI Tech. (Gr) 6.59 1.10% 5.90% 0.00% -33.00%
    Alliance New Millenn (Gr) 9.60 1.10% 6.10% 0.00% -37.20%
    Tata IT Sector Fund 13.79 0.90% 6.70% 119.60% 29.90%
    Sun F&C Emerg Tech (Gr) 7.61 0.50% 4.40% 0.00% -11.10%

    IT funds continued to see rapid growth. With the run-up in the prices of Infosys and Satyam (the cornerstone of most portfolios) IT funds continued to do well. All funds in this category witnessed growth over the week and the month. UTI’s Software fund was the star performer brushing aside misconceptions that private funds are better performers vis-ŕ-vis public sector funds.

    Open-ended, Pharma Funds NAV
    Magnum Sector Funds-Pharma 10.16 3.10% 5.40% 0.00% 0.90%
    K P Pharma (Gr) 10.26 2.30% 1.90% 8.50% 8.10%
    UTI Sector-Pharma 10.51 1.60% 3.40% 0.00% -11.90%

    Pharma funds also witnessed NAV appreciation. Indian pharma stocks (Ranbaxy, Cipla, Dr Reddy) had some role to play in this. MNC pharma stocks remained steady. Buying by retail investors and institutions implies that there is appetite for pharma stocks. SBI’s Magnum Pharma was the outperformer over the week and the month.

    Open-ended, FMCG Funds NAV
    Magnum Sector Funds-FMCG 8.97 1.80% 3.00% 0.00% -13.10%
    K P FMCG (Gr) 12.01 0.80% 2.00% 10.40% 18.60%
    Pru ICICI FMCG (Gr) 10.03 0.60% 3.50% -4.70% -2.30%

    Performance of FMCG funds’ can at best be described as staid, compared to IT and pharma. However, all FMCG funds were in the positive over the week. The reasons are not hard to find – all FMCG funds have taken large exposures to Hindustan Lever which is on a roll. (Incidentally Hindustan Lever went ex-split this week and buying interest continued to remain high).

    As in pharma, SBI’s Magnum FMCG was most impressive over the week and the month. However, it improved over a much lower base, when compared to Kothari FMCG and Pru-ICICI FMCG.

    Public sector funds seem to be creeping into the limelight very slowly. This is evident from the fact that all the three sectoral star performers (UTI and SBI MF) were from the public sector.



    Equitymaster requests your view! Post a comment on "Sectoral Funds – Weekly roundup". Click here!


    More Views on News

    The Right Financial Advisor Is Around the Corner (Outside View)

    Mar 10, 2016

    An opportunity to find an impeccably trustworthy and competent financial guardian is in the offing.

    Why financial planning should be dull and boring (Mutual Fund Corner)

    Feb 29, 2016

    Most financial planners come out as whiz kids who throw around financial jargon. But financial planning can be actually easy, provided one follows a disciplined approach.

    What Are E-Wallets And How To Use Them (Mutual Fund Corner)

    Feb 12, 2016

    PersonalFN highlights the benefits of parking a portion of your expenses in e-wallets and using them efficiently.

    Is Consumption Boom Over In India? (Mutual Fund Corner)

    Feb 2, 2016

    Mutual funds take a bearish call on the FMCG sector. The sector has started playing out due to a combination of slower growth and expensive valuations.

    How to Find a Saint Amongst Sinners? (Mutual Fund Corner)

    Feb 1, 2016

    Ethical practices help build long lasting relationships, and healthy long-term business relationships are often mutually rewarding. But PersonalFN is of the view that the financial services industry in India seems to have forgotten this.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

    Aug 4, 2017

    The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms